View webcasting trends and the forces that drive them
When Antisoma did its first webcast late last year, the London-based bio-pharmaceutical concern was hoping to attract new investors from outside its domestic market. Valerie Tate, Antisoma's investor relations officer, says, 'We decided to bite the bullet because this seemed like a tremendous opportunity to raise our profile not just in the UK but outside the UK as well.'For her first webcast, Tate chose an occasion that she felt would appeal to German investors: Antisoma was licensing a product
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
